BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11468695)

  • 1. Pleomorphic (giant and/or spindle cell) carcinoma of lung shows a high percentage of variant CYP1A12.
    Przygodzki RM; Koss MN; O'Leary TJ
    Mol Diagn; 2001 Jun; 6(2):109-15. PubMed ID: 11468695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP1A1 gene polymorphism and risk of epithelial ovarian neoplasm.
    Aktas D; Guney I; Alikasifoglu M; Yüce K; Tuncbilek E; Ayhan A
    Gynecol Oncol; 2002 Aug; 86(2):124-8. PubMed ID: 12144816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms.
    Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T
    Oncol Rep; 2004 Oct; 12(4):773-9. PubMed ID: 15375499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population.
    Nakachi K; Imai K; Hayashi S; Kawajiri K
    Cancer Res; 1993 Jul; 53(13):2994-9. PubMed ID: 8319207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleomorphic (giant and spindle cell) carcinoma is genetically distinct from adenocarcinoma and squamous cell carcinoma by K-ras-2 and p53 analysis.
    Przygodzki RM; Koss MN; Moran CA; Langer JC; Swalsky PA; Fishback N; Bakker A; Finkelstein SD
    Am J Clin Pathol; 1996 Oct; 106(4):487-92. PubMed ID: 8853037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP1A1 Ile462Val polymorphism and the risk of non-small cell lung cancer in a Chinese population.
    Lin J; He B; Cao L; Zhang Z; Liu H; Rao J; Liu Y; Shao S; Wang G; Zhang X
    Tumori; 2014; 100(5):547-52. PubMed ID: 25343551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polymorphisms of the CYP1A1 and GSTM1 genes and their combined effects on individual susceptibility to lung cancer in a Chinese population].
    Xue K; Xu L; Chen S; Ma G; Wu J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Apr; 18(2):125-7. PubMed ID: 11295132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers.
    Yu MW; Chiu YH; Yang SY; Santella RM; Chern HD; Liaw YF; Chen CJ
    Br J Cancer; 1999 May; 80(3-4):598-603. PubMed ID: 10408872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cytochrome P450 1A1 and uridine-diphosphate-glucuronosyltransferase 1A1 allelic polymorphisms on the risk of development and the prognosis of head and neck cancers.
    Szanyi I; Ráth G; Móricz P; Somogyvári K; Révész P; Gerlinger I; Orsós Z; Ember I; Kiss I
    Eur J Cancer Prev; 2012 Nov; 21(6):560-8. PubMed ID: 22273851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms of cytochrome P450 1A1 and risk of gallbladder cancer.
    Tsuchiya Y; Sato T; Kiyohara C; Yoshida K; Ogoshi K; Nakamura K; Yamamoto M
    J Exp Clin Cancer Res; 2002 Mar; 21(1):119-24. PubMed ID: 12071517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association of CYP1A1 Ile462Val polymorphisms with susceptibility to small cell lung cancer].
    He B; Lin J; Cao L; Wang H; Rao J; Liu Y; Zhang Z
    Wei Sheng Yan Jiu; 2014 May; 43(3):393-6, 418. PubMed ID: 24964616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP1A1 Ile462Val polymorphism contributes to lung cancer susceptibility among lung squamous carcinoma and smokers: a meta-analysis.
    Ji YN; Wang Q; Suo LJ
    PLoS One; 2012; 7(8):e43397. PubMed ID: 22952673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP1A1 gene polymorphisms: lack of association with breast cancer susceptibility in the southern region (Madurai) of India.
    Kiruthiga PV; Kannan MR; Saraswathi C; Pandian SK; Devi KP
    Asian Pac J Cancer Prev; 2011; 12(8):2133-8. PubMed ID: 22292665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of CYP1A1 gene polymorphism using designed RFLP and distributions of CYP1A1 genotypes in Japanese.
    Oyama T; Mitsudomi T; Kawamoto T; Ogami A; Osaki T; Kodama Y; Yasumoto K
    Int Arch Occup Environ Health; 1995; 67(4):253-6. PubMed ID: 7591186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP1A1 gene polymorphism and risk of endometrial hyperplasia and endometrial carcinoma.
    Esinler I; Aktas D; Alikasifoglu M; Tuncbilek E; Ayhan A
    Int J Gynecol Cancer; 2006; 16(3):1407-11. PubMed ID: 16803538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP1A1 polymorphisms and risk of lung cancer in the ethnic Kashmiri population.
    Shaffi SM; Shah MA; Bhat IA; Koul P; Ahmad SN; Siddiqi MA
    Asian Pac J Cancer Prev; 2009; 10(4):651-6. PubMed ID: 19827888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/Msp-GSTM1*0/*0 genotypes.
    Rojas M; Alexandrov K; Cascorbi I; Brockmöller J; Likhachev A; Pozharisski K; Bouvier G; Auburtin G; Mayer L; Kopp-Schneider A; Roots I; Bartsch H
    Pharmacogenetics; 1998 Apr; 8(2):109-18. PubMed ID: 10022748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between CYP1A1 aryl hydrocarbon hydroxylase activity and lung cancer in a Japanese population.
    Kiyohara C; Nakanishi Y; Inutsuka S; Takayama K; Hara N; Motohiro A; Tanaka K; Kono S; Hirohata T
    Pharmacogenetics; 1998 Aug; 8(4):315-23. PubMed ID: 9731718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens.
    Le Marchand L; Sivaraman L; Pierce L; Seifried A; Lum A; Wilkens LR; Lau AF
    Cancer Res; 1998 Nov; 58(21):4858-63. PubMed ID: 9809991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP1A1 and GSTM1 polymorphisms in relation to lung cancer risk in Chinese women.
    Yang XR; Wacholder S; Xu Z; Dean M; Clark V; Gold B; Brown LM; Stone BJ; Fraumeni JF; Caporaso NE
    Cancer Lett; 2004 Oct; 214(2):197-204. PubMed ID: 15363546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.